Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 15, 2007

View Archived Issues

Nastech reacquires teriparatide nasal spray for osteoporosis from Procter & Gamble

Novel MAO-B inhibitors developed at Roche

Novel antiinfective agents disclosed in recent patent literature

SantoSolve raises USD 7 million to support initiation of phase III clinical trial of 2-PX

Studies show reduced albuminuria with aliskiren in diabetes patients

Neuroprotective gene in AD identified by Siena Biotech

FDA accepts Chelsea Therapeutics' IND for droxidopa

Synvista Therapeutics initiates phase II clinical trial of alagebrium for chronic heart failure

BioMS Medical enrolls first 133 patients in MAESTRO-03 phase III trial of MBP-8298

Novel treatment option for transplant rejection imparted in recent Novartis patent

Lexicon submits NDA to FDA for LX-2931 for rheumatoid arthritis

New antiinflammatory agents disclosed in recent Kalypsys and Abbott patents

Actelion initiates CONSCIOUS-2 phase III study of endothelin receptor antagonist Pivlaz

Synta initiates SYMMETRY phase III clinical trial of elesclomol in metastatic melanoma

ImmuneRegen reports positive findings on effectiveness of Viprovex against flu virus

Rigel reports positive results from phase II clinical study of R-788

Acambis collaborates with sanofi pasteur to develop West Nile virus vaccine

TMC-125: Study results presented at the 11th European AIDS Conference

MLN-1202 lowers CRP in patients with atherosclerotic cardiovascular disease risk

Prucalopride well tolerated and improves bowel function in chronic constipation

Declines in HCV RNA seen with VCH-759 in multiple-dose study

SEACOAST study reveals efficacy of Simcor in dyslipidemia

PD-0348292 inhibits thrombosis in pigs undergoing iliac venous stent placement

Anti-HCV effect of R-1626 with peginterferon alfa-2a, R-1626 resistance studied

Enrollment begins for RH1 study in solid tumors or non-Hodgkin's lymphoma

FDA grants fast track status to Crucell's rabies monoclonal antibody cocktail

E.U. approves Pegintron/Rebetol therapy for HCV patients failing interferon therapy

FDA approves Mircera for renal anemia indication

Mitsubishi Tanabe receives Japanese approval for extended indication of Remicade

Fastic/Starsis receives approval for supplemental NDA in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...